Cargando…
Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines
Colorectal cancer (CRC) is one of the main causes of cancer-related death in developed countries. Targeted therapies and conventional chemotherapeutics have been developed to help treat this type of aggressive cancer. Among these, the monoclonal antibodies cetuximab (Cxm) and panitumumab specificall...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281214/ https://www.ncbi.nlm.nih.gov/pubmed/32375292 http://dx.doi.org/10.3390/membranes10050091 |
_version_ | 1783543870718476288 |
---|---|
author | Cortese, Katia Marconi, Silvia Aiello, Cinzia Gagliani, Maria Cristina Pilato, Serena Zappacosta, Romina Fontana, Antonella Castagnola, Patrizio |
author_facet | Cortese, Katia Marconi, Silvia Aiello, Cinzia Gagliani, Maria Cristina Pilato, Serena Zappacosta, Romina Fontana, Antonella Castagnola, Patrizio |
author_sort | Cortese, Katia |
collection | PubMed |
description | Colorectal cancer (CRC) is one of the main causes of cancer-related death in developed countries. Targeted therapies and conventional chemotherapeutics have been developed to help treat this type of aggressive cancer. Among these, the monoclonal antibodies cetuximab (Cxm) and panitumumab specifically target and inactivate the signaling of ERBB1 (EGF receptor), a key player in the development and progression of this cancer. Unfortunately, these antibodies are effective only on a small fraction of patients due to primary or secondary/acquired resistance. However, as ERBB1 cell surface expression is often maintained in resistant tumors, ERBB1 can be exploited as a target to deliver other drugs. Liposomes and immunoliposomes are under intensive investigation as pharmaceutical nanocarriers and can be functionalized with specific antibodies. In this study, we first investigated the anti-cancer activity of a cell permeable tripeptide, leucine-leucin-norleucinal (LLNle), an inhibitor of gamma-secretase and proteasome, in three different CRC cell lines that express ERBB1. We formulated LLNle-liposomes and Cxm-conjugated LLNle-loaded liposomes (LLNle-immunoliposomes) and evaluated their efficacy in inhibiting cell survival. Despite similar pro-apoptotic effects of free LLNle and LLNle-liposomes, immunoliposomes-LLNle were significantly less effective than their unconjugated counterparts. Indeed, immunoliposomes-LLNle were readily internalized and trafficked to lysosomes, where LLNle was likely trapped and/or inactivated. In conclusion, we demonstrated that LLNle was readily delivered to CRC cell lines by liposomes, but immunoliposomes-LLNle failed to show significant anti-cancer activity. |
format | Online Article Text |
id | pubmed-7281214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72812142020-06-15 Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines Cortese, Katia Marconi, Silvia Aiello, Cinzia Gagliani, Maria Cristina Pilato, Serena Zappacosta, Romina Fontana, Antonella Castagnola, Patrizio Membranes (Basel) Article Colorectal cancer (CRC) is one of the main causes of cancer-related death in developed countries. Targeted therapies and conventional chemotherapeutics have been developed to help treat this type of aggressive cancer. Among these, the monoclonal antibodies cetuximab (Cxm) and panitumumab specifically target and inactivate the signaling of ERBB1 (EGF receptor), a key player in the development and progression of this cancer. Unfortunately, these antibodies are effective only on a small fraction of patients due to primary or secondary/acquired resistance. However, as ERBB1 cell surface expression is often maintained in resistant tumors, ERBB1 can be exploited as a target to deliver other drugs. Liposomes and immunoliposomes are under intensive investigation as pharmaceutical nanocarriers and can be functionalized with specific antibodies. In this study, we first investigated the anti-cancer activity of a cell permeable tripeptide, leucine-leucin-norleucinal (LLNle), an inhibitor of gamma-secretase and proteasome, in three different CRC cell lines that express ERBB1. We formulated LLNle-liposomes and Cxm-conjugated LLNle-loaded liposomes (LLNle-immunoliposomes) and evaluated their efficacy in inhibiting cell survival. Despite similar pro-apoptotic effects of free LLNle and LLNle-liposomes, immunoliposomes-LLNle were significantly less effective than their unconjugated counterparts. Indeed, immunoliposomes-LLNle were readily internalized and trafficked to lysosomes, where LLNle was likely trapped and/or inactivated. In conclusion, we demonstrated that LLNle was readily delivered to CRC cell lines by liposomes, but immunoliposomes-LLNle failed to show significant anti-cancer activity. MDPI 2020-05-03 /pmc/articles/PMC7281214/ /pubmed/32375292 http://dx.doi.org/10.3390/membranes10050091 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cortese, Katia Marconi, Silvia Aiello, Cinzia Gagliani, Maria Cristina Pilato, Serena Zappacosta, Romina Fontana, Antonella Castagnola, Patrizio Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title | Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title_full | Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title_fullStr | Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title_full_unstemmed | Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title_short | Liposomes Loaded with the Proteasome Inhibitor Z-Leucinyl-Leucinyl-Norleucinal Are Effective in Inducing Apoptosis in Colorectal Cancer Cell Lines |
title_sort | liposomes loaded with the proteasome inhibitor z-leucinyl-leucinyl-norleucinal are effective in inducing apoptosis in colorectal cancer cell lines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281214/ https://www.ncbi.nlm.nih.gov/pubmed/32375292 http://dx.doi.org/10.3390/membranes10050091 |
work_keys_str_mv | AT cortesekatia liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT marconisilvia liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT aiellocinzia liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT gaglianimariacristina liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT pilatoserena liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT zappacostaromina liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT fontanaantonella liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines AT castagnolapatrizio liposomesloadedwiththeproteasomeinhibitorzleucinylleucinylnorleucinalareeffectiveininducingapoptosisincolorectalcancercelllines |